EGF anticorps (AA 977-1023) (FITC)
-
- Antigène Voir toutes EGF Anticorps
- EGF (Epidermal Growth Factor (EGF))
-
Épitope
- AA 977-1023
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EGF est conjugé à/à la FITC
-
Application
- ELISA
- Purification
- Protein G
- Immunogène
- Recombinant human Pro-epidermal growth factor protein (977-1023AA).
- Isotype
- IgG
- Top Product
- Discover our top product EGF Anticorps primaire
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- 0.01 M PBS, pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Aliquot and store at -20 °C or -80 °C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
-
- Antigène
- EGF (Epidermal Growth Factor (EGF))
- Autre désignation
- Pro-Epidermal Growth Factor (EGF Produits)
- Synonymes
- anticorps HOMG4, anticorps URG, anticorps AI790464, anticorps CEGF, anticorps epidermal growth factor, anticorps pro-epidermal growth factor, anticorps EGF, anticorps egf, anticorps CpipJ_CPIJ020278, anticorps Egf
- ID gène
- 1950
- UniProt
- P01133
- Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
-